VitaRNA is projected to decline to $1.92 by 2027, a -1% move from its current price of $1.95. VITARNA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy. Market sentiment sits at 26/100 (Fear) on the Fear & Greed Index.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via CoinGecko & CoinMarketCap · updated 7/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $1.71 | $1.95 | $2.22 | -0.10% |
| Jul 14 | $1.62 | $1.95 | $2.34 | -0.19% |
| Jul 15 | $1.55 | $1.94 | $2.44 | -0.29% |
| Jul 16 | $1.50 | $1.94 | $2.52 | -0.38% |
| Jul 17 | $1.45 | $1.94 | $2.60 | -0.48% |
| Jul 18 | $1.41 | $1.94 | $2.67 | -0.58% |
| Jul 19 | $1.37 | $1.94 | $2.74 | -0.67% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.37 | $1.94 | $2.74 | -0.67% |
| Week 2 | $1.18 | $1.92 | $3.14 | -1.34% |
| Week 3 | $1.05 | $1.91 | $3.48 | -2.00% |
| Week 4 | $0.9498 | $1.90 | $3.79 | -2.66% |
| Week 5 | $0.8694 | $1.89 | $4.09 | -3.31% |
| Week 6 | $0.802 | $1.87 | $4.37 | -3.96% |
| Week 7 | $0.7443 | $1.86 | $4.65 | -4.61% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
VitaRNA is a token tied to a gene therapy project that tokenizes the Artan Bio IP-NFT through VitaDAO.
It sits within the Ethereum Ecosystem and is categorized under Decentralized Science (DeSci).
This structure connects biotech IP with blockchain-style tokenization, placing VitaRNA in the DeSci space on the Ethereum network.
VitaRNA trades at $1.95 and has a market capitalization of $4.67M, ranking 1592.
The near-term technical setup shows bullish momentum, with RSI14 at 80. The moving averages stand at SMA50 as $0.6622 and SMA200 as $0.4173. Near-term support sits at $0.3773 and resistance at $1.76.
The 30-day price range runs from $0.9523 to $3.99, with an all-time high of $7.46 and an all-time low of $0.1498.
Looking further out, the multi-year forecast points to a bullish trajectory, with 2030 average price at $5.71 (ROI 192.7%) and 2040 average at $16.12 (ROI 726.9%), and a long-run 2050 average of $84.48 (ROI 4232.5%).
A major floor 91.8% below — a decisive break under it would weaken the trend.
The nearest floor, 80.7% below — buyers have tended to step in here.
Resistance now sits 9.8% below — it may act as fresh support.
A major ceiling 37.4% above — clearing it would confirm fresh momentum.
Key VITARNA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of VITARNA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.35 | Buy | $1.40 | Buy |
| MA 10 | $1.21 | Buy | $1.21 | Buy |
| MA 20 | $0.8385 | Buy | $0.98 | Buy |
| MA 50 | $0.6617 | Buy | $0.738 | Buy |
| MA 100 | $0.5266 | Buy | $0.6033 | Buy |
| MA 200 | $0.4172 | Buy | $0.5893 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 75.35 | Sell |
| Stoch RSI (14) | 75.66 | Neutral |
| CCI (20) | 151.07 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.09 | Buy |
| ROC (12) | 216.57 | Buy |
| Bollinger %B (20,2) | 1.03 | Sell |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 3.99 | Buy |
| Awesome (5,34) | 0.67 | Buy |
| Ultimate (7,14,28) | 75.46 | Sell |
| Momentum (10) | 1.26 | Buy |
| Aroon Osc (25) | 100.00 | Buy |
| Hull MA (9) | 1.38 | Buy |
| ADX (14) | 29.91 | Buy |
| ATR (14) | 0.13 | Info |
The 30-day technical picture is bullish, supported by an RSI of 80, indicating strong upside momentum.
SMA50 sits at $0.6622 and SMA200 at $0.4173, with a nearby support around $0.3773 and resistance at $1.76 that frame the near-term path.
The 30-day price range spans $0.9523 to $3.99, highlighting potential volatility within the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.1519 | $1.95 | $2.38 | 0% | Neutral | |
| $1.39 | $1.92 | $2.87 | -1% | Neutral | |
| $2.48 | $3.64 | $5.79 | +87% | Bullish | |
| $3.80 | $5.88 | $9.84 | +202% | Bullish | |
| $3.52 | $5.71 | $9.94 | +193% | Bullish | |
| $2.52 | $4.28 | $7.71 | +119% | Bullish | |
| $4.16 | $7.36 | $13.67 | +277% | Bullish | |
| $7.00 | $12.92 | $24.67 | +563% | Bullish | |
| $7.43 | $14.27 | $27.94 | +632% | Bullish | |
| $4.55 | $9.08 | $18.19 | +366% | Bullish | |
| $7.26 | $16.12 | $35.50 | +727% | Bullish | |
| $38.02 | $84.48 | $194.31 | +42.3x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.1519 | $1.95 | $2.38 | +0.00% |
| August 2026 | $1.37 | $1.67 | $2.13 | -14.29% |
| September 2026 | $1.45 | $1.79 | $2.32 | +6.88% |
| October 2026 | $1.65 | $2.07 | $2.73 | +15.72% |
| November 2026 | $1.54 | $1.94 | $2.59 | -6.22% |
| December 2026 | $1.38 | $1.75 | $2.38 | -9.50% |
Click any year to see its month-by-month VITARNA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The VITARNA price prediction for 2026 points to an average of $1.95 (low $0.1519, high $2.38) — a potential gain of 0% on today's $1.95. Price action looks broadly range-bound.
In 2027, VITARNA is projected to trade between $1.39 and $2.87, averaging $1.92 — a potential decline of -1% from today's $1.95. That is -1% versus the projected 2026 average. A consolidation phase looks the most probable path here.
VitaRNA's 2028 outlook centres on $3.64, within a $2.48 to $5.79 range. That is up +89% on the projected 2027 average. That marks a +87% change versus current levels. Momentum favours further upside here.
By 2029, VITARNA could reach as high as $9.84, with a base case around $5.88 and support toward $3.80 — roughly +202% from $1.95. Buyers look set to stay in control over this stretch.
Expect VITARNA to range from $3.52 to $9.94 through 2030. The $5.71 average target implies a +193% move from current prices. That is -3% versus the projected 2029 average. Momentum favours further upside here.
The VITARNA price prediction for 2031 points to an average of $4.28 (low $2.52, high $7.71) — a potential gain of +119% on today's $1.95. Buyers look set to stay in control over this stretch.
In 2032, VITARNA is projected to trade between $4.16 and $13.67, averaging $7.36 — a potential gain of +277% from today's $1.95. That is up +72% on the projected 2031 average. Momentum favours further upside here.
VitaRNA's 2033 outlook centres on $12.92, within a $7.00 to $24.67 range. That is up +76% on the projected 2032 average. That marks a +563% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, VITARNA could reach as high as $27.94, with a base case around $14.27 and support toward $7.43 — roughly +632% from $1.95. Momentum favours further upside here.
Expect VITARNA to range from $4.55 to $18.19 through 2035. The $9.08 average target implies a +366% move from current prices. That is -36% versus the projected 2034 average. Buyers look set to stay in control over this stretch.
The VITARNA price prediction for 2040 points to an average of $16.12 (low $7.26, high $35.50) — a potential gain of +727% on today's $1.95. Momentum favours further upside here.
In 2050, VITARNA is projected to trade between $38.02 and $194.31, averaging $84.48 — a potential gain of +42.3x from today's $1.95. That is up +424% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in VITARNA today (≈ 512.820513 VITARNA) could be worth
$43,324.74
+$42,324.74 (+4232%) by 2050 · US Dollar
Based on the average projected VITARNA price of $84.48 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in VITARNAwould be worth at today's price.
$1,000 invested in VITARNA on Jul 1, 2025 (≈ 796.960919 VITARNA) would be worth
$1,554.07
+$554.07 (+55.4%) today · 1.55× · US Dollar
Based on a VITARNA entry price of $1.25 vs. today's $1.95.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.01 | $1,926.48 | +92.6% |
| 1 month ago | $0.470392 | $4,145.48 | +314.5% |
| 3 months ago | $0.169973 | $11,472.44 | +1047.2% |
| 6 months ago | $0.442343 | $4,408.35 | +340.8% |
| 1 year ago | $1.25 | $1,554.07 | +55.4% |
| All time (1.1y) ago | $1.65 | $1,182.67 | +18.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our VITARNA forecast.
Our base-case forecast reaches $3.90 around 2029.
Implied market cap at $3.90: $9.33M
The multi-year forecast shows a bullish tilt beginning in 2028, with 2028 at $3.64 on average (86.5% ROI) and 2029 at $5.88 on average (201.7% ROI).
By 2030, the average price is forecast at $5.71 with an ROI of 192.7%, signaling continued upside amid broader momentum. The trajectory remains bullish into 2031–2035, with 2032 at $7.36 average (277.4% ROI) and 2033 at $12.92 average (562.6% ROI).
In the long run, the forecast envisions substantial upside: 2040 at $16.12 average (726.9% ROI) and 2050 at $84.48 average (4232.5% ROI), though these are estimates and not guarantees. The sentiment attached to these years is BULLISH.
Tap a question to reveal the answer.
The forecast for 2030 shows an average price of $5.71 with a ROI of 192.7% and a sentiment of BULLISH (min $3.52, max $9.94).
Near-term forecasts are Neutral for 2026 ($1.95 avg) and 2027 ($1.92 avg) with 0% and -1.4% ROI respectively, but the outlook turns bullish later, with 2040 at $16.12 avg (726.9% ROI) and 2050 at $84.48 avg (4232.5% ROI).
The 2050 forecast max is $194.31, which would exceed $100, while the 2040 max is $35.50. This indicates $100 lies within the modeled upside for the long term.
The 30-day range is from $0.9523 to $3.99.
Current price is $1.95 and the market capitalization is $4.67M, with a market rank of 1592.
VitaRNA Community Discussion
0Share your VitaRNA price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.